https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-25 / Integr Cancer Ther 2018 09;17(3):994-999
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-25 / Integr Cancer Ther 2018 09;17(3):994-9992018-02-25 00:00:002018-02-25 00:00:00Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-23 / Int. J. Oncol. 2018 Apr;52(4):1041-1056
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-23 / Int. J. Oncol. 2018 Apr;52(4):1041-10562018-02-23 00:00:002019-02-15 08:32:54Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-22 / Sci Rep 2018 Feb;8(1):3474
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-22 / Sci Rep 2018 Feb;8(1):34742018-02-22 00:00:002018-02-22 00:00:00Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-21 / Hum Vaccin Immunother 2018 Jun;14(6):1423-1431
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-21 / Hum Vaccin Immunother 2018 Jun;14(6):1423-14312018-02-21 00:00:002018-02-21 00:00:00Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-15 / Blood Rev. 2018 Jul;32(4):312-325
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-15 / Blood Rev. 2018 Jul;32(4):312-3252018-02-15 00:00:002019-02-15 08:32:43Anti-cancer vaccine therapy for hematologic malignancies: An evolving era
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-13 / Nat Rev Urol 2018 Apr;15(4):235-250
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-13 / Nat Rev Urol 2018 Apr;15(4):235-2502018-02-13 00:00:002018-02-13 00:00:00Potentiating prostate cancer immunotherapy with oncolytic viruses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-08 / J Clin Oncol 36, 2018 (suppl 6S; abstr 219)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-08 / J Clin Oncol 36, 2018 (suppl 6S; abstr 219)2018-02-08 00:00:002018-02-08 00:00:00Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-08 / Int. J. Biol. Macromol. 2018 Jul;113:1182-1187
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-08 / Int. J. Biol. Macromol. 2018 Jul;113:1182-11872018-02-08 00:00:002019-02-15 08:35:40Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-08 / JCI Insight 2018 Feb;3(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-08 / JCI Insight 2018 Feb;3(3)2018-02-08 00:00:002019-02-15 08:32:51Efficacy of intracellular immune checkpoint-silenced DC vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2018-02-02 16:13:482019-07-15 15:06:44Immuntherapie beim Prostatakarzinom: Kanadische Arbeitsgruppe stellt den aktuellen Stand vor
